Literature DB >> 7284324

Glucose transport through cell membranes of modified lipid fluidity.

I Yuli, W Wilbrandt, M Shinitzky.   

Abstract

Carrier-mediated transport of glucose in human erythrocytes and 3T3 mouse fibroblasts was examined at different lipid viscosities of the cell membrane. Rigidification of the membrane lipid layer was accomplished by incorporation of cholesterol or one of the hydrophilic esters, cholesteryl hemisuccinate or cholesteryl betainate, whereas fluidization was accomplished by cholesterol depletion. In both cells the dependence of the maximal rate of glucose transport at 37 degrees C, Vmax, on the lipid microviscosity of the cell plasma membrane, eta, is of a similar pattern which does not obey simple diffusion considerations. When the eta value of untreated cells is slightly increased (10-20%), Vmax increases to a peak value, beyond which a further increase in eta progressively reduces it. Decrease of the natural eta is also accompanied by a progressive decrease of Vmax. This general pattern was also observed for the transport of alpha-aminoisobutyric acid in 3T3 fibroblasts (unpublished results). A theoretical analysis of the dependence on eta of the transport turnover number and of the accessibility of carrier sites was carried out in order to account for this behavior. On the basis of this analysis, a general expression for the dependence of Vmax on eta, which fits reasonably well with the experimental data, was derived. This expression is also valid for the dependence on eta of the overt activity of membrane-bound enzymes and receptors.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7284324     DOI: 10.1021/bi00518a003

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  18 in total

1.  Differential effects of permeating and nonpermeating solutes on the fatty acid composition of Pseudomonas putida.

Authors:  L J Halverson; M K Firestone
Journal:  Appl Environ Microbiol       Date:  2000-06       Impact factor: 4.792

2.  Promotion of tumor antigenicity in EL-4 leukemia cells by hydrostatic pressure.

Authors:  L Richert; A Or; M Shinitzky
Journal:  Cancer Immunol Immunother       Date:  1986       Impact factor: 6.968

3.  Membrane Phase-Dependent Occlusion of Intramolecular GLUT1 Cavities Demonstrated by Simulations.

Authors:  Javier Iglesias-Fernandez; Peter J Quinn; Richard J Naftalin; Carmen Domene
Journal:  Biophys J       Date:  2017-03-28       Impact factor: 4.033

4.  Glucose transport and microvillus membrane physical properties along the crypt-villus axis of the rabbit.

Authors:  J B Meddings; D DeSouza; M Goel; S Thiesen
Journal:  J Clin Invest       Date:  1990-04       Impact factor: 14.808

Review 5.  Polarity, diversity, and plasticity in proximal tubule transport systems.

Authors:  R K Kinne
Journal:  Pediatr Nephrol       Date:  1988-10       Impact factor: 3.714

6.  [125I]calmodulin binding to synaptic plasma membrane from rat brain: kinetic and Arrhenius analysis.

Authors:  Z Iqbal; P Y Sze
Journal:  Neurochem Res       Date:  1993-08       Impact factor: 3.996

7.  Insulin stimulation of glucose and amino acid transport in mouse fibroblasts with elevated membrane microviscosity.

Authors:  I Yuli; S Incerpi; P Luly; M Shinitzky
Journal:  Experientia       Date:  1982-09-15

8.  Ischemia induces surface membrane dysfunction. Mechanism of altered Na+-dependent glucose transport.

Authors:  B A Molitoris; R Kinne
Journal:  J Clin Invest       Date:  1987-09       Impact factor: 14.808

9.  2-Deoxy-D-glucose uptake and fatty acid content in fibroblast cultures from children with syndromic paucity of interlobular bile ducts (Alagille syndrome).

Authors:  M Couturier; F Lemonnier
Journal:  J Inherit Metab Dis       Date:  1991       Impact factor: 4.982

10.  Partial purification and kinetic characterization of the microsomal phospholipase A2 from thermally acclimated rainbow trout (Salmo gairdneri).

Authors:  N P Neas; J R Hazel
Journal:  J Comp Physiol B       Date:  1985       Impact factor: 2.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.